MRI of ovarian masses

Journal of Magnetic Resonance Imaging - Tập 37 Số 2 - Trang 265-281 - 2013
Hebert Alberto Vargas1, Tristan Barrett2, Evis Sala2
1Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
2Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, United Kingdom

Tóm tắt

AbstractMRI provides exquisite views of the pelvic anatomy through its high spatial resolution and tissue contrast, and as such plays a key role in the work up of ovarian lesions, identifying features that distinguish benign and malignant lesions. In the case of primary tumors it enables local staging and detection of metastatic disease to help guide management options such as complex surgery or the consideration of neoadjuvant chemotherapy. Functional MRI techniques such as diffusion‐weighted MRI (DW‐MRI), dynamic contrast‐enhanced MRI (DCE‐MRI) and tumor‐selective molecular imaging are currently being evaluated as possible predictive and prognostic biomarkers in the context of ovarian malignancy, and may play a larger role in routine clinical practice in the future. Herein we provide an overview of the conventional and advanced MRI techniques used to characterize ovarian masses and of the role that MR plays in the staging, treatment selection and follow up of patients with ovarian cancer. J. Magn. Reson. Imaging 2013;37:265–281. © 2012 Wiley Periodicals, Inc.

Từ khóa


Tài liệu tham khảo

10.1053/j.ro.2008.06.003

10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S

10.1148/radiol.10090397

10.1148/radiology.201.3.8939226

10.1148/radiology.214.1.r00ja3939

10.1148/radiology.215.3.r00jn25761

10.1016/j.ejrad.2010.01.026

10.2214/ajr.180.5.1801297

10.1016/S0720-048X(97)00122-8

10.1148/radiol.2481071120

10.1148/radiol.10100751

10.1002/jmri.20369

10.1007/s00330-009-1299-4

10.2214/AJR.08.2093

10.1148/rg.305105073

10.1007/s00330-009-1543-y

10.1007/s00330-009-1584-2

10.1148/radiographics.21.1.g01ja14193

Alison SJ, 2007, Gynecology, 22

10.1148/radiographics.20.5.g00se101445

10.1097/00004728-200203000-00015

10.1002/1522-2586(200012)12:6<1014::AID-JMRI29>3.0.CO;2-T

10.1148/rg.226025033

10.1016/j.ijgo.2008.12.015

Edge SB, 2010, AJCC cancer staging manual, 493

10.1016/j.fertnstert.2003.10.004

10.1016/S0033-8389(01)00012-4

10.1007/s00330-010-1886-4

Ricke J, 2003, Prospective evaluation of contrast‐enhanced MRI in the depiction of peritoneal spread in primary or recurrent ovarian cancer, Eur Radiol, 13, 943, 10.1007/s00330-002-1712-8

10.1148/radiol.2482070371

10.1016/S0140-6736(05)66133-8

10.1016/0305-7372(95)90002-0

10.1006/gyno.1995.1121

10.1016/0090-8258(90)90076-W

10.1016/S0002-9378(89)80054-7

10.1148/radiol.2353040447

10.1111/IGC.0b013e3181e0a353

10.1046/j.0007-1323.2001.01947.x

10.1053/crad.2001.0762

10.1148/radiology.218.2.r01ja04365

10.1016/j.ijrobp.2008.08.023

10.2967/jnumed.108.056655

10.1002/mrm.22291

10.1093/annonc/mdq079

10.1038/sj.bjc.6602814

10.1148/radiol.11090563

10.1038/nm.2472

10.1007/s11307-010-0400-3